1 |
Acne Vulgaris Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
2 |
Acromegaly - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
3 |
Actinic Keratosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
4 |
Acute Coronary Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
5 |
Allergic Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
6 |
Allergic Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
7 |
Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
8 |
Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
9 |
Angina - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
10 |
Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
11 |
Aspergillosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
12 |
Autism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
13 |
Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
14 |
Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
15 |
Bacterial Pneumonia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
16 |
B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
17 |
B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
18 |
Behcet's Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
19 |
Biliary Tumor - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
20 |
Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
21 |
Chemotherapy Induced Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
22 |
Chronic Kidney Disease (Chronic Renal Failure) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
23 |
Chronic Liver Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
24 |
Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
25 |
Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
26 |
Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
27 |
Hyperuricemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
28 |
Oral Mucositis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
29 |
Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
30 |
Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
31 |
Open-Angle Glaucoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
32 |
Nosocomial Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
33 |
Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
34 |
Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
35 |
Myelofibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
36 |
Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
37 |
Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
38 |
Nocturia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
39 |
Myasthenia Gravis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
40 |
Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
41 |
Metastatic Hepatocellular Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
42 |
Medullary Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
43 |
Malignant Mesothelioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
44 |
Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
45 |
Metastatic Renal Cell Carcinoma (mRCC) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
46 |
Anterior Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
47 |
Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
48 |
Blepharitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
49 |
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
50 |
Dyspepsia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
51 |
Endometriosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
52 |
Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
53 |
Venous Thromboembolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
54 |
Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
55 |
Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
56 |
Esophageal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
57 |
Febrile Neutropenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
58 |
Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
59 |
Familial Amyloid Polyneuropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
60 |
Gastrointestinal Stromal Tumor (GIST) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
61 |
Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
62 |
Hairy Cell Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
63 |
Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
64 |
Hematopoietic Stem Cell Transplantation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
65 |
Hemophilia B - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
66 |
Hemostasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
67 |
Hepatitis D - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
68 |
Hypertriglyceridemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
69 |
Hot Flashes - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
70 |
Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
71 |
Idiopathic Pulmonary Fibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
72 |
Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
73 |
Hypersomnia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
74 |
Hyperphosphatemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
75 |
Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
76 |
Gastritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
77 |
Gastroparesis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
78 |
Idiopathic Short Stature - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
79 |
Infantile Spasm - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
80 |
Ischemic Stroke - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
81 |
Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
82 |
Left Ventricular Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
83 |
Liposarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
84 |
Liver Failure - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
85 |
Moderate Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
86 |
Lupus Nephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
87 |
Paroxysmal Nocturnal Hemoglobinuria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
88 |
Partial Seizure - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
89 |
Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
90 |
Impetigo - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
91 |
Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
92 |
Influenza A Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
93 |
Waldenstrom Macroglobulinemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
94 |
Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
95 |
Otitis Media - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
96 |
Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
97 |
Peptic Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
98 |
Insulin Resistance - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
99 |
Iron Deficiency Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
100 |
Short Bowel Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
101 |
Varicella Zoster (HHV-3) Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
102 |
Vancomycin-Resistant Enterococcus Faecium Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
103 |
Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
104 |
Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
105 |
Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
106 |
Peripheral Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
107 |
Pruritus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
108 |
Tourette Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
109 |
Urinary Incontinence - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
110 |
Uterine Leiomyoma (Uterine Fibroids) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
111 |
Sarcoidosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
112 |
Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
113 |
Sinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
114 |
Sleep Apnea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
115 |
Smallpox - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
116 |
Soft Tissue Sarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
117 |
Spasticity - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
118 |
Spinal Muscular Atrophy (SMA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
119 |
Systemic Lupus Erythematosus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
120 |
Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
121 |
Systemic Mastocytosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
122 |
Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
123 |
Phenylketonuria (PKU) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
124 |
Rhinosinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
125 |
Rosacea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
126 |
Seasonal Allergic Rhinitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
127 |
Secondary Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
128 |
Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
129 |
Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
130 |
Seizures - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
131 |
Severe Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
132 |
Thrombocytopenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
133 |
Thrombotic Thrombocytopenic Purpura - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
134 |
Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
135 |
Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
136 |
Polycythemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
137 |
Traveler's Diarrhea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
138 |
Pompe Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
139 |
Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
140 |
Post Menopausal Osteoporosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
141 |
Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
142 |
Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
143 |
Pouchitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
144 |
Premature Ejaculation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
145 |
Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
146 |
Primary Biliary Cirrhosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
147 |
Primary Immune Deficiency (PID) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
148 |
Psoriatic Arthritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
149 |
Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
150 |
Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
151 |
Pyelonephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
152 |
Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
153 |
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
154 |
Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
155 |
Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
156 |
Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
157 |
Renal Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
158 |
Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
159 |
Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
160 |
Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|